Program

Program

Note: Timings below are listed in Australian Eastern Daylight Time (AEDT). To check your time zone please click here.

MONDAY 22 MARCH 2021

RANZCR Radiation Oncology Trainee SMART Workshop

 

1030 – 1045 Welcome and Introduction
Dr Giuseppe Sasso, President of TROG Cancer Research
1045 – 1050 Sponsor’s Address
Mr Ben Wadling, AstraZeneca

Introduction of SMART Facilitators and Biostatisticians
1050 – 1105 Introduction to Critical Appraisal – “Do we really need it? Aren’t papers already peer reviewed?”
Dr Kristy Robledo, Prof Val Gebski, Mr Chris Brown & Dr Trang Pham
1105 – 1120 Issues with Randomised Controlled Trials: Key Concepts and Question Time
Dr Kristy Robledo, Prof Val Gebski & Mr Chris Brown

  • Randomisation
  • Strata
  • Allocation concealment
1120 – 1200 Small Group Session 1
Dr Kristy Robledo, Prof Val Gebski, Mr Chris Brown, A/Prof Sandra Turner, Dr Keen Hun Tai, A/Prof Shankar Siva, Dr Rahul Mukherjee, A/Prof David Pryor, Dr Eric Hau, Dr Jane Ludbrook, A/Prof Gerry Hanna & A/Prof Puma Sundaresan
1200 – 1245 LUNCH BREAK
Meeting Hub | Meet with Delegates in the Meeting Hub
1245 – 1300 Time to Event Concepts: Key Concepts and Question Time
Dr Kristy Robledo, Prof Val Gebski & Mr Chris Brown

  • Censored Observations
  • Survival Curves
  • Estimates from These Curves and Comparisons
  • Follow-Up Issues
  • Comparison
  • Quantifying Risk
1300 – 1350 Small Group Session 2
Dr Kristy Robledo, Prof Val Gebski, Mr Chris Brown, A/Prof Sandra Turner, Dr Keen Hun Tai, A/Prof Shankar Siva, Dr Rahul Mukherjee, A/Prof David Pryor, Dr Eric Hau, Dr Jane Ludbrook, A/Prof Gerry Hanna & A/Prof Puma Sundaresan
1350 – 1405 Local Guest Speaker
Prof Michael Barton OAM
Radiation Oncologist, University of New South Wales
1405 – 1420 Local Guest Speaker
A/Prof. Shankar Siva
Radiation Oncologist, Peter MacCallum Cancer Centre
1420 – 1430 Guest Speaker Question Time
1430 – 1445 AFTERNOON BREAK
Meeting Hub | Meet with Delegates in the Meeting Hub
1445 – 1500 Interpretation of Clinical Trial Results: Key Concepts and Question Time
Dr Kristy Robledo, Prof Val Gebski & Mr Chris Brown

  • Intention to Treat / per Protocol
  • Multiple Outcomes
  • Tweaking Study Designs
  • Subgroups Analyses
  • Interim Analyses
1500 – 1550 Small Group Session 3
Dr Kristy Robledo, Prof Val Gebski, Mr Chris Brown, A/Prof Sandra Turner, Dr Keen Hun Tai, A/Prof Shankar Siva, Dr Rahul Mukherjee, A/Prof David Pryor, Dr Eric Hau, Dr Jane Ludbrook, A/Prof Gerry Hanna & A/Prof Puma Sundaresan
1550 – 1630 Open Forum Q&A
Dr Trang Pham, A/Prof Sandra Turner, Dr Keen Hun Tai, A/Prof Shankar Siva, Dr Rahul Mukherjee, A/Prof David Pryor, Dr Eric Hau, Dr Jane Ludbrook, Mr Chris Brown, Dr Kristy Robledo, Prof Val Gebski, A/Prof Gerry Hanna & A/Prof Puma Sundaresan
1630 Wrap Up – Closing
Dr Trang Pham

 

TUESDAY 23 MARCH 2021

0900 – 1030 OPENING PLENARY
0900 – 0905 Acknowledgement of Country
Mr Luther Cora
0905 – 0915 Official Welcome & Housekeeping
Dr Renee Finnigan & Dr John Shakeshaft
ASM C0-Convenors
0915 – 0945 Update of NRG Activities and Future Directions for Collaborative Research
Prof Sue Yom
0945 – 1015 Recent Developments/Emerging Research in Head & Neck/Lung Cancer
Prof Sue Yom
1015 – 1030 TROG Scientific Committee Update
Prof Trevor Leong
1030 – 1045

MORNING BREAK

Meeting Hub | Meet with Delegates in the Meeting Hub
Exhibition | Browse the Exhibition

1045 – 1215 PLENARY 2: LUNG CANCER RESEARCH PORTFOLIO
1045 – 1100

BREAKING NEWS: TRIALS WITH NEW RESULTS

Chairs: Dr Fiona Hegi-Johnson & Dr Yu Yang Soon

TROG 13.01 / ALTG 13.001 SAFRON II – Stereotactic Ablative Fractionated Radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the Lung: A Randomised Phase II Trial (Cat A | Open)
A/Prof Shankar Siva

1100 – 1115

PROPOSALS UNDER DEVELOPMENT / TRIALS IN START-UP

Chairs: Dr Jane Ludbrook & Dr Fiona Hegi-Johnson

TROG 20.01 CHEST RT – Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer with Thoracic Radiotherapy (Cat A | Start Up)
Dr Eric Hau

1115 – 1125

OPEN TRIALS WITH CHALLENGES

Chairs: Dr Yu Yang Soon & Dr Jane Ludbrook

TROG 17.02 OUTRUN – Randomised Phase II Trial of Osimertinib with or without Stereotactic Radiosurgery for EGFR Mutated NSCLC with Brain Metastases (Cat A | Open)
Dr Fiona Hegi-Johnson

1125 – 1215

 

Horizon Scanning

Chair: Dr Fiona Hegi-Johnson

Dr Jane Ludbrook
Dr Yu Yang Soon
Dr Eric Hau
Prof Shalini Vinod

1215 – 1245

LUNCH BREAK

Meeting Hub | Meet with Delegates in the Meeting Hub
Exhibition | Browse the Exhibition

1245 – 1415 PLENARY 3: HEAD, NECK AND SKIN CANCER RESEARCH PORTFOLIO TECHNICAL RESEARCH WORKSHOP:
TROG RADIATION THERAPY QUALITY ASSURANCE

Chairs: Dr Charles Lin & Dr Lachlan McDowell

1245 – 1250
Introduction and Housekeeping
Dr Charles Lin

Breaking Trials with New Results or Updates

1250 – 1300
TROG 08.05 WBRT | MASC 01.07 – Whole Brain Radiotherapy Following Local Treatment of Intracranial Metastases of Melanoma – A Randomised Phase III Trial (Cat C | Open)
A/Prof Angela Hong

1300 – 1305
TROG 12.01 HPV OROPHARYNX – A Randomised Trial of Weekly Cetuximab and Radiation versus Weekly Cisplatin and Radiation in Good Prognosis Loco Regionally Advanced HPV-Associated Oropharyngeal Squamous Cell Carcinoma (Cat A | Open)
Prof Danny Rischin

1305 – 1325
Secondary Analyses

1305 – 1309
RTQA (TROG 12.01)
Prof June Corry

1309 – 1313
PRO (TROG 12.01)
Dr Lachlan McDowell

1313 – 1317
SHOUT (TROG 12.01)
Dr Laurelie Wishart

1317 – 1321
Prognostic Indicators
Dr Sweet Ping Ng

1321 – 1325
TROG 17.10 ReHUM – Re analysis of the TROG 07.03 RadioHUM Study using Deformable Image Registration to Predict Patterns of Failure in Head and Neck Cancer Patients Undergoing Treatment with IMRT or 3DCRT
Dr Charles Lin on behalf of Dr Noel Aherne

Proposals Under Development/Trials in Start Up

1325 – 1330
TROG 19.07 UTILITY Unilateral Treatment in all Well-Lateralized Tonsillar Primary Tumours (Cat C)
Dr Lachlan McDowell

1330 – 1340
TROG 20M IMAT | MASC 03.18 – A Randomised, Placebo-Controlled, Phase II Trial of Adjuvant Avelumab in Patients with Stage I-III Merkel Cell Carcinoma (Cat C)
Dr Wen Xu

Trials on Hold

1340 – 1345
TROG 17.11 C-POST | R2810-ONC-1788 – A Randomised, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab versus Placebo after Surgery and Radiation Therapy in Patients with High Risk Cutaneous Squamous Cell Carcinoma (Cat C)
Prof Danny Rischin

1345 – 1415
Horizon Scanning: Future Directions and Opportunities

Dr Charles Lin
A/Prof Ben Chua
Dr Lachlan McDowell
Prof Danny Rischin
Prof Liz Kenny AO
Dr Andrew Macann
A/Prof Puma Sundaresan
Dr Chris Wratten
A/Prof Brett Hughes

Chairs: Mr Dean Wilkinson & Dr Nick Hardcastle

1245 – 1250
Welcome and Introduction to the TRW
Ms Laurel Schmidt

1250 – 1255
Sponsor’s Address
Mr Sean Watson

1255 – 1305
TROG RTQA: Update, Knowledge-Based Planning, Awards and More….
Mrs Alisha Moore

1305 – 1320
Sensitivity of Patient Specific Quality Assurance (SEAFARER)
A/Prof Joerg Lehmann

1320 – 1335
Australian Clinical Dosimetry Service – Updates, Collaborations and Focus for the Future (SABR, SRS & MR-Linac)
Ms Rhonda Brown

1335 – 1400
Particle Therapy Workshops – Insights and Overview. Collaborative Presentation – Peter MacCallum Cancer Centre, Royal Adelaide Hospital, Royal Brisbane and Women’s Hospital, Westmead Hospital
Dr Adam Yeo & Dr Jonathan Sykes

1400 – 1415
The Radiotherapy Atlas Contouring Tool (TRAC) for Automated Clinical Trial QA – The Future of Clinical Trial RTQA?
Mr Phillip Chlap

 

1415 – 1430 AFTERNOON BREAK
Meeting Hub | Meet with Delegates in the Meeting Hub
Exhibition | Browse the Exhibition
1430 – 1600 PLENARY 4: OPTIMISING THE COMBINATION OF NOVEL THERAPIES WITH RADIATION THERAPY IN OLIGOMETASTATIC DISEASE

TECHNICAL RESEARCH WORKSHOP: TECHNOLOGY DRIVEN CLINICAL TRIALS

Chairs: A/Prof Ben Chua & Dr Eric Hau Chairs: Prof Tomas Kron & Mr Fahim Siddiqi
1430 – 1450 Combining SABR and Drugs for Metastases Outside the Brain
A/Prof Shankar Siva
1430 – 1440
Motion Management Strategies – Overview and Interactive Q&A
Dr Nick Hardcastle
1450 – 1510 Combining Radiotherapy and Drugs for Brain Metastases
A/Prof Mark Pinkham
Speaker sponsored by
1440 – 1455
TROG 15.03 FASTRACKII – Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney – A Phase II Clinical Trial (Cat A | Open): Knowledge Based Planning and Imaging Sub-Studies
Dr Nick Hardcastle
1510 – 1525 Integration of Novel Treatments from the Medical Oncology Perspective
A/Prof Chee Lee
1455 – 1510
Liver SBRT Motion Management using KIM: USYD/TROG 17.03 LARK – Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM) (Cat A | Open)
Dr Trang Nguyen
1525 – 1540 Ethics in Practice: Clinical Equipoise, and Navigating Unchartered Territory in Translational Research
Dr Linda Sheahan
1510 – 1525
Liver SBRT Planning and Treatment – Challenges and Opportunities: USYD/TROG 17.03 LARK
Mr Timothy Blacketer
1540 – 1600 Panel Discussion & Horizon Scanning 1525 – 1540
MRI Based Prostate Planning: TROG 18.01 NINJA (Novel Integration of New Prostate Radiation Schedules with adJuvant Androgen Deprivation) (Cat A | Open): Substudy – Update and what is Coming Next?
Prof Peter Greer
1540– 1555
TROG 18.06 FIG (FET-PET in Glioblastoma) Trial (Cat A | Open) – Technical Challenges and Practice Changing Ideas
A/Prof Eng Siew Koh
1555– 1600
Virtual Yoga
1600 – 1700 EXPANDING THE TROG PORTFOLIO

 

1600 – 1630

Chairs: Ms Laurel Schmidt & A/Prof Joerg Lehmann

Technology Special Interest Groups – Update, Progress, Achievements: Particle Therapy and MRI in Radiation Therapy
Prof Farshad Foroudi & A/Prof Hien Le

1630 – 1645 Artificial Intelligence in Radiation Therapy: Is there a Role in Clinical Trials?
Prof Annette Haworth
1645 – 1700 EBRT Following Interventional Oncology – Scenarios, Challenges and Opportunities
Dr Richard Khor & Dr Dinesh Ranatunga
1700 – 1730

SPEED NETWORKING

Your opportunity to meet colleagues and speakers through small group meetings, to discuss a number of topics. Participants will be randomly allocated through a progression of six-person-five-minute video group chats.

Conversation Starters

17001705: Round 1

Professional topic -What do you see as the biggest challenge/opportunity facing research in radiation oncology?
Personal Topic
– What do you enjoy most about your job?

1705 – 1710: Round 2

Professional topic – Artificial intelligence – will your job ever be obsolete?
Personal Topic
– Space travel vs deep ocean submarine exploration – which would you choose if given the chance, and why?

1710 – 1715: Round 3

Professional topic – Do you think TROG should consider trials for brachytherapy?
Personal Topic
– If you could spend one day in someone else’s shoes, who would it be and why?

1715 – 1720: Round 4

Professional topic – What has been the greatest challenge/achievement of your career so far?
Personal Topic
– Which “bucket list” activity (that you have completed) most exceeded expectations and why?

1720 – 1725: Round 5

Professional topic – Have you ever knowingly used artificial intelligence based systems?
Personal Topic
– Procrastination – what is your personal productivity kryptonite?

1725 – 1730: Round 6

Professional topic – What advice would you give to someone just starting out in research?
Personal Topic
– Are you scared about how much your internet browser knows about you? Why/Why not?

1745 – 1830

SYMPOSIUM: CONSIDERATIONS OF THORACIC RADIATION IN THE IMMUNOTHERAPY ERA

1745 – 1750 Session Introduction
Prof Shalini Vinod
1750 – 1802

Considerations for RT in ES-SCLC Patients Treated with Immunotherapy
Dr Eric Hau

1802 – 1814

How do we Administer CRT to Unresectable Stage III NSCLC Patients with Consolidation IO Treatment in Mind?
A/Prof Gerry Hanna

1814 – 1830

Panel Discussion: Best Practice Shared Care Arrangements between Radiation and Medical Oncology

Prof Shalini Vinod
A/Prof Gerry Hanna
Dr Eric Hau

Dr Melissa Moore

 

WEDNESDAY 24 MARCH 2021

0745 – 0815 BREAKFAST SESSION: Digital Health Interventions (DHI) Echoing Patient’s Voice-Electronic Patient Reported Outcomes in Cancer Care
Prof Vesa Kataja

Sponsored by

0815 – 0845 BREAKFAST SESSION: From SFRT to Immunotherapy: Translational Advances in Radiation Research
Debanti Sengupta

Sponsored by

0900 – 1030 PLENARY 5: EMERGING TECHNOLOGIES
0900 – 0915

Chairs: A/Prof Peter Gorayski & Prof Paul Keall

New Techniques and Technologies Committee Update
Prof Tomas Kron & A/Prof Joerg Lehmann

0915 – 0935 Technical Considerations and Future Directions of Proton Therapy
Prof Sung Yong Park
0935 – 0955 Clinical Considerations and Future Directions of Proton Therapy
A/Prof Melvin Chua Lee Kiang
0955 – 1020 MRI Linac in Clinical Practice: Fully Adaptive Radiotherapy
Dr Jeremy De Leon
Speaker sponsored by
1020 – 1030 Panel Discussion
Prof Tomas Kron
A/Prof Joerg Lehmann
Prof Sung Yong Park
A/Prof Melvin Chua Lee Kiang
Dr Jeremy De Leon
1030 – 1045

MORNING BREAK

Meeting Hub | Meet with Delegates in the Meeting Hub Exhibition | Browse the Exhibition

1045 – 1215 PLENARY 6: GENITOURINARY CANCER RESEARCH PORTFOLIO
Chairs: A/Prof Shankar Siva & Dr Stephen Chin
1045 – 1105 TROG 08.03 RAVES – A Phase III Multi-Centre Randomised Trial Comparing Adjuvant RT with Early Salvage RT in Patients with Positive Margins or Extra Prostatic Disease following Radical Prostatectomy (Cat A | Open)
A/Prof Andrew Kneebone
1105 – 1125 TD 20.02 CHyPPR – A Phase 3 Randomised Controlled Trial of Conventional Versus HYpofractionated Post Prostatectomy Radiotherapy (Cat A | In Development)
Dr Stephen Chin
1125– 1140 TROG 19.06 DECREASE – DarolutamidE + Consolidation RadiothErapy in Advanced proStatE Cancer Detected by PSMA (Cat A | Start Up)
A/Prof Shankar Siva
1140 – 1150 ICR-CTSU/2015/10052 TROG 16.03 CORE – A Randomised Trial of Conventional Care versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases (Cat B | Open)
A/Prof David Pryor
1150 – 1215 Genitourinary Working Party Update and Strategy Meeting Summary
A/Prof Shankar Siva
Dr Stephen Chin
A/Prof David Pryor
Dr Jarad Martin
Prof Paul Keall
Ms Alison Brown
1215 – 1245

LUNCH BREAK

Meeting Hub | Meet with Delegates in the Meeting Hub Exhibition | Browse the Exhibition

1245 – 1415 PLENARY 7: BREAST CANCER RESEARCH PORTFOLIO
Chairs: Prof Boon Chua & Dr Peta Lonski
1245– 1305 TROG 14.04 Heart Avoiding Radiation Therapy (HART): Final Analysis and Research Directions (Cat A | Closed)
Prof Tomas Kron
1305 – 1325 MRI-Guided Breast Radiotherapy: Background and Future Concept Possibilities
A/Prof Farshad Foroudi
1325 – 1345 Radiomics in Breast Cancer
Dr Will Rae
1345– 1410 BIG 3-07/TROG 07.01 Randomised Phase III Study of Radiation Doses and Fractionation in Non-Low Risk DCIS of the Breast: 5-Year Main Analysis (Cat A | Open)
Prof Boon Chua
1410 – 1415 Automated Gross Tumour Volume Contour Generation in Radiomics Research
Prof Tomas Kron
1415 – 1430

AFTERNOON BREAK

Meeting Hub | Meet with Delegates in the Meeting Hub Exhibition | Browse the Exhibition

1430 – 1600 CLOSING PLENARY

 

1430 – 1440

Chairs: Prof Trevor Leong & A/Prof Puma Sundaresan

Trial Update: CCTG SC24 TROG 17.06 – A Phase III Randomized Feasibility Study Comparing Stereotactic Body Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Patients with Spinal Metastases (Cat B | Closed)
A/Prof Shankar Siva

1440 – 1450 Trial Update: CKTO 2006-04 TROG 08.04 PORTEC – Randomised Phase III Trial Comparing Concurrent Chemoradiation and Adjuvant Chemotherapy with Pelvic Radiation Alone in High Risk and Advanced Stage Endometrial Carcinoma (Cat C | Open)
Dr Pearly Khaw
1450 – 1500 Trial Update: TROG 18.06 FIG – FET-PET in Glioblastoma (Cat A | Open)
A/Prof Eng-Siew Koh
1500 – 1520 Future Directions in Cranial Radiosurgery
A/Prof Matthew Foote
1520 – 1540 Paediatrics
Dr Greg Wheeler
1540 – 1555 President’s Report (including TROG Awards)
Dr Giuseppe Sasso
1555 – 1557 Platform Gamification Prize Draw
Mr Benjamin Moore
1557 – 1600 Closing Remarks
Dr Renee Finnigan & Dr John Shakeshaft
ASM Co-Convenors

* Please note this program is subject to change.

 

ASM Countdown

Important Dates

Registration

Now Open

Early Bird Registration Closes

5 February 2021